Cite

HARVARD Citation

    Okusaka, T. et al. (2016). Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment. Cancer science. 107 (12), pp. 1791-1799. [Online]. 
  
Back to record